These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 672574)

  • 1. [Piracetam--a drug for decreasing potency?].
    Hofmann N
    Med Welt; 1978 Jun; 29(26):1096-9. PubMed ID: 672574
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effectiveness of piracetam in tardive dyskinesia - double-blind cross-over controlled trial with a placebo].
    Kabes J; Sikora J; Starý O; Pisvejc J; Hanzlícek L
    Cesk Psychiatr; 1983 Oct; 79(5):339-45. PubMed ID: 6357509
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of piracetam on the brain-organic psychosyndrome in cerebrovascular insufficiency. Results of a double-blind study in 40 cases].
    Trabant R; Poljakovic Z; Trabant D
    Ther Ggw; 1977 Aug; 116(8):1504-21. PubMed ID: 331549
    [No Abstract]   [Full Text] [Related]  

  • 4. The efficacy of piracetam in vertigo. A double-blind study in patients with vertigo of central origin.
    Oosterveld WJ
    Arzneimittelforschung; 1980; 30(11):1947-9. PubMed ID: 7006617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Management of neuroleptic side-effects with piracetam (author's transl)].
    Sikora J; Kabes J; Pisvejc J
    Cesk Psychiatr; 1981 Apr; 77(2):137-42. PubMed ID: 6114800
    [No Abstract]   [Full Text] [Related]  

  • 6. A double-blind investigation of piracetam (nootropil) versus placebo in the memory of geriatric inpatients.
    Abuzzahab FS; Merwin GE; Zimmermann RL; Sherman MC
    Psychopharmacol Bull; 1978 Jan; 14(1):23-5. PubMed ID: 343146
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cognitive function in alcoholics in a double-blind study of piracetam].
    Buranji I; Skocilić Z; Kozarić-Kovacić D
    Lijec Vjesn; 1990; 112(3-4):111-4. PubMed ID: 2204773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of therapeutic response to long-term treatment with lecithin versus piracetam plus lecithin in patients with Alzheimer's disease.
    Smith RC; Vroulis G; Johnson R; Morgan R
    Psychopharmacol Bull; 1984; 20(3):542-5. PubMed ID: 6433396
    [No Abstract]   [Full Text] [Related]  

  • 9. A controlled clinical trial on the effect of piracetam in epileptic children.
    Kunneke PS; Malan GM
    Br J Clin Pract; 1979 Sep; 33(9):266-71. PubMed ID: 385029
    [No Abstract]   [Full Text] [Related]  

  • 10. [Piracetam in premature biological aging. Double-blind study after preselection by drugs].
    Dorn M
    Fortschr Med; 1978 Aug; 96(30):1525-30. PubMed ID: 669550
    [No Abstract]   [Full Text] [Related]  

  • 11. A double-blind, placebo-controlled study of piracetam in elderly psychiatric patients [proceedings].
    Chouinard G; Annable L; Ross-Chouinard A; Olivier M; Fontaine F
    Psychopharmacol Bull; 1981 Jan; 17(1):129. PubMed ID: 7232645
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of piracetam in children with learning disorders.
    Simeon J; Waters B; Resnick M
    Psychopharmacol Bull; 1980 Jul; 16(3):65-6. PubMed ID: 7403408
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of piracetam on extrapyramidal side effects induced by neuroleptic drugs.
    Kabes J; Sikora J; Pisvejc J; Hanzlicek L; Skondia V
    Int Pharmacopsychiatry; 1982; 17(3):185-92. PubMed ID: 6128331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nootropic drugs: effects and effectiveness. A reflection exemplified by a phase III study using piracetam].
    Herrmann WM; Kern U
    Nervenarzt; 1987 Jun; 58(6):358-64. PubMed ID: 3302738
    [No Abstract]   [Full Text] [Related]  

  • 15. [Piracetam in the treatment of alcohol-induced delirium].
    Snel H; Lehmann E; Velikonja M
    MMW Munch Med Wochenschr; 1983 Oct; 125(42):947-9. PubMed ID: 6417503
    [No Abstract]   [Full Text] [Related]  

  • 16. A double blind trial of piracetam (UCB 6215) and placebo in cases of post-ECT cognitive deficiency.
    Bagadia VN; Gada MT; Mundra VK; Simon S; Doshi JM; Pradhan PV; Shah LP; Sheth UK
    J Postgrad Med; 1980 Apr; 26(2):116-20. PubMed ID: 7012328
    [No Abstract]   [Full Text] [Related]  

  • 17. [Piracetam in the treatment of soft tissue rheumatism].
    Glas-Schöttl R
    Fortschr Med; 1989 Apr; 107(13):298-302. PubMed ID: 2656442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A controlled trial of piracetam in intellectually impaired patients with Parkinson's disease.
    Sano M; Stern Y; Marder K; Mayeux R
    Mov Disord; 1990; 5(3):230-4. PubMed ID: 2388639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of the therapeutic effectiveness of a piracetam plus dihydroergocristine combination in the treatment of vertigo].
    López Martínez R
    Acta Otorrinolaringol Esp; 1988; 39(4):287-8. PubMed ID: 3152560
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pilot study of 2-pyrrolidon-acetamid (generic name: piracetam) (author's transl)].
    Tacke B; Freistein H; Kempf H; Windheuser A
    Pharmakopsychiatr Neuropsychopharmakol; 1975 Mar; 8(2):82-9. PubMed ID: 788004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.